Stratos Wealth Partners LTD. Sells 1,649 Shares of Agilent Technologies, Inc. $A

Stratos Wealth Partners LTD. decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 4.0% in the second quarter, Holdings Channel.com reports. The firm owned 39,685 shares of the medical research company’s stock after selling 1,649 shares during the period. Stratos Wealth Partners LTD.’s holdings in Agilent Technologies were worth $4,683,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. raised its stake in Agilent Technologies by 13.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company’s stock valued at $4,279,000 after buying an additional 4,362 shares during the last quarter. Alps Advisors Inc. raised its position in shares of Agilent Technologies by 29.5% in the 1st quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company’s stock worth $1,563,000 after purchasing an additional 3,040 shares during the last quarter. D.A. Davidson & CO. boosted its stake in Agilent Technologies by 30.4% in the 1st quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company’s stock worth $1,108,000 after purchasing an additional 2,207 shares in the last quarter. LGT Capital Partners LTD. boosted its stake in Agilent Technologies by 7.6% in the 1st quarter. LGT Capital Partners LTD. now owns 768,252 shares of the medical research company’s stock worth $89,870,000 after purchasing an additional 54,302 shares in the last quarter. Finally, Live Oak Investment Partners purchased a new stake in Agilent Technologies during the 1st quarter valued at about $603,000.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a report on Wednesday, October 8th. Rothschild Redb upgraded shares of Agilent Technologies to a “strong-buy” rating in a report on Wednesday, October 8th. UBS Group raised Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price objective for the company from $130.00 to $170.00 in a research report on Wednesday, October 8th. Barclays increased their target price on Agilent Technologies from $125.00 to $150.00 and gave the company an “equal weight” rating in a research note on Thursday, October 2nd. Finally, Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research note on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $149.62.

Agilent Technologies Price Performance

NYSE A opened at $142.01 on Friday. The stock has a market capitalization of $40.26 billion, a price-to-earnings ratio of 33.34, a PEG ratio of 4.63 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The business’s fifty day moving average price is $127.58 and its 200-day moving average price is $117.84.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the prior year, the business earned $1.32 earnings per share. Agilent Technologies’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.